Dar Al-Shifa Pharmaceuticals. Co. announced unaudited preliminary financial results for year ended December 31, 2013.

For the period, the company's net profit after taxes reached $2,117,685, compared with a net profit after taxes of $2,027,972 in the audited data for 2012, a net increase of 4.4%.